← Back to catalogue

NeuroFlex

FDA UDI

Class II (US FDA UDI)

by Saccade Analytiques Inc

Identity

Trade Name
NeuroFlex FDA UDI
Generic Name
Eye-tracking neurological/brain injury assessment device FDA UDI
Model / Reference
NeuroFlex FDA UDI

Identifiers

Primary DI / UDI-DI
G676NEUROFLEX0 FDA UDI
FDA Product Code
PTY FDA UDI
GMDN Term
Eye-tracking neurological/brain injury assessment device FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
882.1470 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

Yes

FDA UDI

Lot / Batch Number

No

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Eye-tracking neurological/brain injury assessment device

NeuroFlex by Saccade Analytiques Inc — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Eye-tracking neurological/brain injury assessment device.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI dec355c3-162b-49b7-9378-4f80baa9fe31 32 fields · synced Jun 8, 2026